Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Developmental Trajectory of Cancer-Related Cognitive Impairment in Breast Cancer Patients: A Systematic Review of Longitudinal Neuroimaging Studies
Helena Sousa, Susana Almeida, João M. Bessa, et al.
Neuropsychology Review (2020) Vol. 30, Iss. 3, pp. 287-309
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Chemotherapy‐induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021
Omid Amani, Mohammad Ali Mazaheri, Mona Malekzadeh, et al.
Cancer Reports (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 12
Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
Neuropsychological Interventions for Cancer-Related Cognitive Impairment: A Network Meta-Analysis of Randomized Controlled Trials
Andy S. K. Cheng, Xiaoming Wang, Niu Niu, et al.
Neuropsychology Review (2022) Vol. 32, Iss. 4, pp. 893-905
Closed Access | Times Cited: 28
Cognitive impairment following breast cancer treatments: an umbrella review
Giulia Oliva, Andreina Giustiniani, Laura Danesin, et al.
The Oncologist (2024) Vol. 29, Iss. 7, pp. e848-e863
Open Access | Times Cited: 7
Natural trajectory subclasses of cognitive impairment in breast cancer patients experiencing insomnia
Oxana Palesh, Sarah Braun, Tina Truong, et al.
Cancer (2025) Vol. 131, Iss. 8
Open Access
Brain gray matter reduction and premature brain aging after breast cancer chemotherapy: a longitudinal multicenter data pooling analysis
Michiel B. de Ruiter, Rachael Deardorff, Jeroen Blommaert, et al.
Brain Imaging and Behavior (2023) Vol. 17, Iss. 5, pp. 507-518
Closed Access | Times Cited: 12
The prevalence of mild cognitive impairment in breast cancer patients receiving chemotherapy according to the criteria of the National Institute on Aging-Alzheimer’s Association (NIA-AA)
Elaine A. C. Albers, Jacobien M. Kieffer, Sanne B. Schagen
Journal of Cancer Survivorship (2024)
Open Access | Times Cited: 4
A study on the changes of white matter microstructure in breast cancer patients undergoing chemotherapy based on DTI technology
Yuan Li, Yaqi Song, Zhe Sun, et al.
Acta Radiologica (2025)
Closed Access
Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer Based on Functional Assessment and NIRS Analysis
Noelia Durán-Gómez, Casimiro Fermín López-Jurado, Marta Nadal-Delgado, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2363-2363
Open Access | Times Cited: 17
Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy
Brenna C. McDonald, Kathleen Van Dyk, Rachael Deardorff, et al.
Breast Cancer Research and Treatment (2022) Vol. 194, Iss. 1, pp. 113-126
Open Access | Times Cited: 16
Cognitive alterations and brain functional changes following chemotherapy treatment in breast cancer patients: A systematic review on resting-state fMRI studies
L Conti, Silvia Francesca Maria Pizzoli, Chiara Marzorati, et al.
Applied Neuropsychology Adult (2024), pp. 1-16
Open Access | Times Cited: 3
Altered gyrification in chemotherapy‐treated older long‐term breast cancer survivors
Ebenezer Daniel, Frank Deng, Sunita K. Patel, et al.
Brain and Behavior (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 3
Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: A systematic review
Gwen Schroyen, Julie Vissers, Ann Smeets, et al.
Translational Oncology (2021) Vol. 16, pp. 101297-101297
Open Access | Times Cited: 19
Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe
Charlotte Sleurs, Ali Amidi, Lisa M. Wu, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103859-103859
Open Access | Times Cited: 13
Interventions promoting cognitive function in patients experiencing cancer related cognitive impairment: A systematic review
Laura Oldacres, Josephine Hegarty, Patricia O’Regan, et al.
Psycho-Oncology (2022) Vol. 32, Iss. 2, pp. 214-228
Open Access | Times Cited: 13
A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissue
Jan Petr, Louise Hogeboom, Pavel Nikulin, et al.
Magnetic Resonance Materials in Physics Biology and Medicine (2021) Vol. 35, Iss. 1, pp. 163-186
Open Access | Times Cited: 14
Role of Cytokines in Chemotherapy-related Cognitive Impairment of Breast Cancer Patients: A Systematic Review
Mohd Ashif Khan, Kanika Tyagi, Md Masoom, et al.
Current Reviews in Clinical and Experimental Pharmacology (2022) Vol. 18, Iss. 2, pp. 110-119
Closed Access | Times Cited: 9
Mapping cognitive deficits in cancer patients after chemotherapy: An Activation Likelihood Estimation meta-analysis of task-related fMRI studies
Jacqueline B Saward, Elizabeth G. Ellis, Annalee L. Cobden, et al.
Brain Imaging and Behavior (2022) Vol. 16, Iss. 5, pp. 2320-2334
Open Access | Times Cited: 9
Functional changes of the prefrontal cortex, insula, caudate and associated cognitive impairment (chemobrain) in NSCLC patients receiving different chemotherapy regimen
Siwen Liu, Jie Ni, Fei Yan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Neuroimaging based biotypes for precision diagnosis and prognosis in cancer-related cognitive impairment
Shelli R. Kesler, Ashley M. Henneghan, Sarah Prinsloo, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Pre-Surgery Demographic, Clinical, and Symptom Characteristics Associated with Different Self-Reported Cognitive Processes in Patients with Breast Cancer
Yu-Yin Allemann-Su, Marcus Vetter, Helen Koechlin, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3281-3281
Open Access | Times Cited: 8
Neuroinflammation as potential precursor of leukoencephalopathy in early-stage breast cancer patients: A cross-sectional PET-MRI study
Gwen Schroyen, Charlotte Sleurs, Emilie Bartsoen, et al.
The Breast (2022) Vol. 62, pp. 61-68
Open Access | Times Cited: 6
Dynamic functional network connectivity reveals the brain functional alterations in lung cancer patients after chemotherapy
Lanyue Hu, Shaohua Ding, Yujie Zhang, et al.
Brain Imaging and Behavior (2021) Vol. 16, Iss. 3, pp. 1040-1048
Closed Access | Times Cited: 8
Characterizing Early Changes in Quality of Life in Young Women With Breast Cancer
Hend M. Al‐Kaylani, Bradley T. Loeffler, Sarah L. Mott, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 5
Emotional, inflammatory, and genetic factors of resilience and vulnerability to depression in patients with premenopausal breast cancer: A longitudinal study protocol
Susana Almeida, Magda A. Oliveira, Rui Medeiros, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0279344-e0279344
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top